GJIA
ORMP icon

Glass Jacobson Investment Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.7K Hold
10,540
– – 0.02% 326
2026
Q1 		$35.8K Hold
10,540
– – 0.01% 354
2025
Q4 		$30K Hold
10,540
– – 0.01% 367
2025
Q3 		$27.8K Hold
10,540
– – 0.01% 364
2025
Q2 		$23.7K Hold
10,540
– – 0.01% 370
2025
Q1 		$25.5K Hold
10,540
– – 0.01% 475
2024
Q4 		$25.5K Hold
10,540
– – 0.01% 475
2024
Q3 		$25.7K Hold
10,540
– – 0.01% 458
2024
Q2 		$27.1K Hold
10,540
– – 0.01% 434
2024
Q1 		$30.8K Hold
10,540
– – 0.01% 425
2023
Q4 		$24.3K Sell
10,540
-1,715
-14% -$3.66K 0.01% 421
2023
Q3 		$32K Hold
12,255
– – 0.01% 369
2023
Q2 		$43.9K Buy
+12,255
New +$39.3K 0.02% 339
2022
Q4 		$112K Buy
+9,350
New +$72.7K 0.06% 254

Other funds holding ORMP

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
SCM
Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFO
Pioneer Family Office North Miami Beach, Florida $194M AUM
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Glass Jacobson Investment Advisors's ORMP Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Oramed Pharmaceuticals (ORMP) position steady in Q2 2026 at 10,540 shares worth $50.7K. The position accounts for 0.02% of the portfolio, ranked #326.

Glass Jacobson Investment Advisors first reported a position in ORMP in Q4 2022 and has held it in 14 quarters since. The position peaked at $112K in Q4 2022. 14 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Glass Jacobson Investment Advisors held 10,540 shares of Oramed Pharmaceuticals worth $50.7K as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Oramed Pharmaceuticals share count unchanged in Q2 2026.
  • Oramed Pharmaceuticals made up 0.02% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #326 holding.
  • Glass Jacobson Investment Advisors first reported a position in Oramed Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's Oramed Pharmaceuticals position peaked at $112K in Q4 2022.
  • 14 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.